Skip to main content
Clinical Trials/NCT02826122
NCT02826122
Completed
Not Applicable

Prevalence of Diastolic Dysfunction and Effects of Conservative Lifestyle Treatment in Patients With Morbid Obesity

Norwegian University of Science and Technology1 site in 1 country57 target enrollmentAugust 2016
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Norwegian University of Science and Technology
Enrollment
57
Locations
1
Primary Endpoint
diastolic dysfunction
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The Purpose of this study is to 1) investigate prevalence of diastolic dysfunction in patients with morbid obesity attending a conservative lifestyle change program, 2) investigate effects on cardiac function, cardiorespiratory Fitness, body composition, quality of life and cardiovascular risk through the program, 3) investigate feasibility of introducing two different activity monitors throughout the program, and 4) comparing compliance to activity sensor market leader FitBit Application versus Mio Pai Application

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
August 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • BMI \> 40 kg/m2 (or BMI \> 35 kg/m2 with comorbidity)
  • Stable weight last Three months (≤ 2 kg variation)
  • Norwegian speaking
  • Smartphone

Exclusion Criteria

  • Other weight reduction treatment, including medication affecting appetite
  • Known chronic cardiac condition
  • Previous bariatric surgery
  • Alcohol or other substitute abuse
  • Psychiatric disorder needing treatment, including eating disorders
  • Pregnancy or planned pregnancy during project period

Outcomes

Primary Outcomes

diastolic dysfunction

Time Frame: 18 months

echocardiac examination at baseline assessed by GE Healthcare Vivid E9, Horten, Norway

Secondary Outcomes

  • LDL concentration in blood(18 months)
  • Lp(a) concentration in blood serum(18 months)
  • Concentration of HS-CRP in blood serum(18 months)
  • C-peptide concentration in blood(18 months)
  • Apo-A concentration in blood serum(18 months)
  • Glucose concentration in blood(18 months)
  • NT-ProBNP concentration in plasma(18 months)
  • Physical Activity Questionnaire(18 months)
  • diastolic function(12 months)
  • Symptoms of anxiety and depression(18 months)
  • HDL concentration in blood(18 months)
  • Cardiorespiratory fitness(18 months)
  • Waist line(18 months)
  • Quality of life(18 months)
  • Concentration of triglycerides in blood serum(18 months)
  • Sodium (Na) concentration in blood(18 months)
  • Apo-B concentration in blood serum(18 months)
  • Body composition(18 months)
  • Body Mass Index(18 months)
  • Glycosylated haemoglobin (HbA1c) concentration in blood(18 months)
  • Concentration of total cholesterol in blood(18 months)
  • Creatinine concentration in blood(18 months)
  • Leukocyte concentration in blood(18 months)
  • Potassium (K) concentration in blood(18 months)

Study Sites (1)

Loading locations...

Similar Trials